Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue 2, 2008, Pages 139-142

  Kütükçüler, Necil ^a   Karaca, Neslihan E ^a   Sözeri, Betül Y ^a   Koturoǧlu, Güldane ^a   Kurugöl, Zafer ^a   Özyürek, Ruhi A ^a   Aksu, Güzide ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acute rheumatic fever; Interleukin 1 receptor antagonist; Soluble tumor necrosis factor receptor I

Indexed keywords

ACETYLSALICYLIC ACID; BENZATHINE PENICILLIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PENICILLIN G; PREDNISOLONE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ARTICLE; CARDITIS; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; NONHUMAN; POLYARTHRITIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REMISSION; RHEUMATIC FEVER; SCHOOL CHILD; STREPTOCOCCUS GROUP A;

ACUTE DISEASE; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RHEUMATIC HEART DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 42549085204     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Markowitz M. Pioneers and modern ideas: rheumatic fever-a half-century perspective. Pediatrics 1998; 102: 272-4.
2. Carapetis J R, Mc Donald M, Wilson N. Acute rheumatic fever Lancet 2005; 366: 115-68.
3. Özer S, Hallioǧlu O, Özkutlu S, Çeliker A, Alehan D, Karagöz T. Childhood acute rheumatic fever in Ankara, Turkey. Turk J Pediatr 2005; 47: 120-4.
4. Read SE, Reid FM, FischettiVA, Poon-King T, Kamkissoon R, McDowell M, et al. Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. J Clin Immunol 1906; 6: 433-41.
5. Kemeny E, Grive T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989; 52: 225-37.
6. Gaur U, Aggarwal B, Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403-8.
7. Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, Perez-Hernandez N, Fragoso JM, Saul A, et al. Tumor necrosis factor-α promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 2003; 21: 59-63.
8. Yeǧin O, Coşkun M, Ertuǧ H. Cytokines in acute rheumatic fever. Eur J Pediatr 1997; 156: 25-9.
9. Samsonov MY, Tilz GP, Pisklakov VP, Reibnegger G, Nassonov EL, Nassonona VA, et al. Serum soluble receptors for tumor necrosis factor-alpha, interleukin-2, and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 1995; 74: 31-4.
10. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic disease. Arhritis Rheum 1992; 35: 1160-9.
11. Miller LC, Gray ED, Mansour M, Abdin ZH, Kamel R, Zaher S. Cytokines and immunoglobulin in rheumatic heart disease; production by blood and tonsillar mononuclear cells. J Rheumatol 1989; 16: 1436-42.
12. Morris K, Mohan C, Wahi P, Anand I.S, Ganguly NK. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease: a prospective study. Clin Exp Immunol 1993; 91: 429-36.
13. Narin N, Kütükçüler N, Özyürek R, Bakiler A R, Parlar A, Arcasoy M. Lymphocyte subsets and plasma IL-1, IL-2, and TNF alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol and Immunopathol 1995; 77: 172-6.
14. Kütükçüler N, Narin N. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease. Scand J Rheumatol 1995;24: 383-5.
15. Van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum 1995; 38: 164-72.
16. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompsom FIC. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Aced Sci USA 1991; 88: 5232-6.
17. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin-1 receptor antagonist-deficient mice. J Exp Med 2000; 191: 313-20.
18. Aksu G, Bayram N, Ülger Z, Öztürk C, Özyurek RA, Bakiler RA, Kütükçüler N. Inverse relationship between the ratio of ICAM-1 expressing lymphocytes and serum TGF-beta1 concentrations in acute rheumatic fever. J Autoimmun 2005; 25: 141-9.
19. Dajani AS, Ayoub E, Bierman FZ, Bisno AL, Denny FW, Durack DT, et al. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, updated 1992 Circulation 1993; 87: 302-7.
20. Groeneveld AB, Tacx AN, Bossink AW, van Mierlo GJ, Hack CE. Circulating inflammatory mediators predict shock and mortality in febrile patientswith microbial infection. Clin Immunol 2003; 106: 106-15.
21. Setiady YY, Pramoonjago P, Tung KS. Requirements of NK cells and proinflammatory cytokines in T cell-dependent neonatal autoimmune ovarian disease triggered by immune complex. J Immunol 2004; 173: 1051-8.